1. Home
  2. PRGO vs HROW Comparison

PRGO vs HROW Comparison

Compare PRGO & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$12.27

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$40.24

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRGO
HROW
Founded
1887
1998
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
PRGO
HROW
Price
$12.27
$40.24
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$19.33
$69.86
AVG Volume (30 Days)
2.2M
443.5K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
10.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$800,000.00
N/A
Revenue This Year
N/A
$31.62
Revenue Next Year
$1.02
$50.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.23
$21.18
52 Week High
$28.44
$54.98

Technical Indicators

Market Signals
Indicator
PRGO
HROW
Relative Strength Index (RSI) 61.66 53.84
Support Level $12.17 $36.75
Resistance Level $15.08 $41.67
Average True Range (ATR) 0.47 1.67
MACD 0.04 0.11
Stochastic Oscillator 76.52 54.63

Price Performance

Historical Comparison
PRGO
HROW

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: